AstraZeneca : AZN

All AstraZeneca Articles

221 Articles

Douglas A. McIntyre | Jan 30, 2009 at 8:01 AM EST

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

These are some of the many pre-market downgrades and negative calls we have seen from Wall Street analysts this Friday…

Douglas A. McIntyre | Jan 30, 2009 at 7:55 AM EST

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday…

Douglas A. McIntyre | Jul 8, 2008 at 1:38 PM EDT

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic…

Douglas A. McIntyre | May 16, 2008 at 7:26 AM EDT

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to…

Douglas A. McIntyre | Apr 1, 2008 at 6:39 AM EDT

Top 10 Pre-Market Analyst Calls (AKAM, MO, AZN, GSK, HES, LVLT, PEP, PIR, UBS, VMW)

These aren’t the only impact analyst calls this morning, but these are the ones we are focusing the Tuesday in…

Douglas A. McIntyre | Mar 19, 2008 at 6:36 AM EDT

Top 10 Pre-Market Analyst Calls (AZN, BG, CCJ, CFC, DWSN, INAP, LAMR, MNST, NCC, SGEN)

Below are the ten analyst calls that 247WallSt.com is focusing on in pre-market trading this Wednesday morning: AstraZeneca (NYSE: AZN)…

Douglas A. McIntyre | Mar 13, 2008 at 6:24 AM EDT

Top 10 Pre-Market Analyst Calls (AIG, AZN, GLUU, GSIC, HOLX, HUM, JASO, LEAP, MON, WBD)

These are not the only analyst calls this morning, but these are 10 impact calls we are reviewing this Thursday…

Douglas A. McIntyre | Mar 12, 2008 at 12:59 PM EDT

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

CyDex Pharmaceuticals, Inc. has filed to come public via an IPO in what it lists for filing purposes as up…

Douglas A. McIntyre | Dec 28, 2007 at 3:01 PM EST

52-Week Low Club (December 28, 2007)

Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close. But…

Douglas A. McIntyre | Jun 8, 2007 at 3:29 PM EDT

52-Week Low Club (June 8, 2007)

Stock Tickers: AZN, BCRX, EHTH, CTIC, HW, NRMX, SBUX, WFMI, DUK It’s no secret we had the makings of a…

Douglas A. McIntyre | Jun 6, 2007 at 7:13 AM EDT

Pre-Market Stock News (June 6, 2007)

(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded…

1 … 13 14 15

AstraZeneca : AZN

All AstraZeneca Articles

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Top 10 Pre-Market Analyst Calls (AKAM, MO, AZN, GSK, HES, LVLT, PEP, PIR, UBS, VMW)

Top 10 Pre-Market Analyst Calls (AZN, BG, CCJ, CFC, DWSN, INAP, LAMR, MNST, NCC, SGEN)

Top 10 Pre-Market Analyst Calls (AIG, AZN, GLUU, GSIC, HOLX, HUM, JASO, LEAP, MON, WBD)

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

52-Week Low Club (December 28, 2007)

52-Week Low Club (June 8, 2007)

Pre-Market Stock News (June 6, 2007)

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

AstraZeneca : AZN

All AstraZeneca Articles

Top Pre-Market Analyst Downgrades (ALL, AZN, ETFC, FITB, JNPR, QCOM, RF, RYAAY, SEPR, HOT, TKR, TWC, TROW, UA, VE, ZNT)

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Top 10 Pre-Market Analyst Calls (AKAM, MO, AZN, GSK, HES, LVLT, PEP, PIR, UBS, VMW)

Top 10 Pre-Market Analyst Calls (AZN, BG, CCJ, CFC, DWSN, INAP, LAMR, MNST, NCC, SGEN)

Top 10 Pre-Market Analyst Calls (AIG, AZN, GLUU, GSIC, HOLX, HUM, JASO, LEAP, MON, WBD)

IPO FILING: CyDex Pharmaceuticals, Inc. (CYDX, PFE, BMY, AZN)

52-Week Low Club (December 28, 2007)

52-Week Low Club (June 8, 2007)

Pre-Market Stock News (June 6, 2007)

History Says This Unstoppable Dow Juggernaut Is a No-Brainer Buy Right Now

Lucid Stock Is Deeply Oversold and We See 45% Gains Ahead

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

Featured Reads

The $1,847 Monthly Survivor Benefit Most Widows Leave on the Table by Filing at the Wrong Age

The West's Home Prices Just Fell 1.4% While the Rest of America Climbed. Here's Why.